Wang Zheng, Malanoski Anthony P, Lin Baochuan, Kidd Carolyn, Long Nina C, Blaney Kate M, Thach Dzung C, Tibbetts Clark, Stenger David A
Center for Bio/Molecular Science & Engineering, Naval Research Laboratory, Washington, DC 20375, USA.
BMC Genomics. 2008 Dec 1;9:577. doi: 10.1186/1471-2164-9-577.
Febrile respiratory illness (FRI) has a high impact on public health and global economics and poses a difficult challenge for differential diagnosis. A particular issue is the detection of genetically diverse pathogens, i.e. human rhinoviruses (HRV) and enteroviruses (HEV) which are frequent causes of FRI. Resequencing Pathogen Microarray technology has demonstrated potential for differential diagnosis of several respiratory pathogens simultaneously, but a high confidence design method to select probes for genetically diverse viruses is lacking.
Using HRV and HEV as test cases, we assess a general design strategy for detecting and serotyping genetically diverse viruses. A minimal number of probe sequences (26 for HRV and 13 for HEV), which were potentially capable of detecting all serotypes of HRV and HEV, were determined and implemented on the Resequencing Pathogen Microarray RPM-Flu v.30/31 (Tessarae RPM-Flu). The specificities of designed probes were validated using 34 HRV and 28 HEV strains. All strains were successfully detected and identified at least to species level. 33 HRV strains and 16 HEV strains could be further differentiated to serotype level.
This study provides a fundamental evaluation of simultaneous detection and differential identification of genetically diverse RNA viruses with a minimal number of prototype sequences. The results demonstrated that the newly designed RPM-Flu v.30/31 can provide comprehensive and specific analysis of HRV and HEV samples which implicates that this design strategy will be applicable for other genetically diverse viruses.
发热性呼吸道疾病(FRI)对公众健康和全球经济有重大影响,并且在鉴别诊断方面构成了一项艰巨挑战。一个特别的问题是检测基因多样的病原体,即人类鼻病毒(HRV)和肠道病毒(HEV),它们是FRI的常见病因。重测序病原体微阵列技术已显示出同时鉴别诊断多种呼吸道病原体的潜力,但缺乏一种用于为基因多样的病毒选择探针的高可信度设计方法。
以HRV和HEV作为测试案例,我们评估了一种用于检测基因多样的病毒并进行血清分型的通用设计策略。确定了数量最少的可能能够检测HRV和HEV所有血清型的探针序列(HRV为26个,HEV为13个),并将其应用于重测序病原体微阵列RPM-Flu v.30/31(Tessarae RPM-Flu)。使用34株HRV和28株HEV毒株验证了所设计探针的特异性。所有毒株均成功检测到并至少鉴定到种水平。33株HRV毒株和16株HEV毒株能够进一步鉴别到血清型水平。
本研究对使用最少数量的原型序列同时检测和鉴别基因多样的RNA病毒进行了基础评估。结果表明,新设计的RPM-Flu v.30/31能够对HRV和HEV样本进行全面且特异的分析,这意味着该设计策略将适用于其他基因多样的病毒。